GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (HKSE:01349) » Definitions » EV-to-FCF

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co (HKSE:01349) EV-to-FCF : 3,048.38 (As of Apr. 21, 2025)


View and export this data going back to 2002. Start your Free Trial

What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Enterprise Value is HK$5,288.9 Mil. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was HK$1.7 Mil. Therefore, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's EV-to-FCF for today is 3,048.38.

The historical rank and industry rank for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's EV-to-FCF or its related term are showing as below:

HKSE:01349' s EV-to-FCF Range Over the Past 10 Years
Min: -96.69   Med: -5   Max: 3032.74
Current: 3032.74

During the past 13 years, the highest EV-to-FCF of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co was 3032.74. The lowest was -96.69. And the median was -5.00.

HKSE:01349's EV-to-FCF is ranked worse than
98.72% of 546 companies
in the Drug Manufacturers industry
Industry Median: 23.31 vs HKSE:01349: 3032.74

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-21), Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's stock price is HK$2.35. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was HK$0.043. Therefore, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's PE Ratio (TTM) for today is 54.65.


Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co EV-to-FCF Historical Data

The historical data trend for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co EV-to-FCF Chart

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.44 14.10 25.60 -44.86 -23.12

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Quarterly Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -44.86 -59.98 -58.30 83.36 -

Competitive Comparison of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's EV-to-FCF falls into.


;
;

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co EV-to-FCF Calculation

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=5288.938/1.735
=3,048.38

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's current Enterprise Value is HK$5,288.9 Mil.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$1.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co  (HKSE:01349) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=2.35/0.043
=54.65

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's share price for today is HK$2.35.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0.043.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Business Description

Traded in Other Exchanges
Address
308 Cailun Road, Zhangjiang Hi-Tech Park, Pudong, Shanghai, CHN, 201210
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is engaged in the research, development, manufacturing, and sale of biopharmaceutical products. Its product portfolio includes ALA (Aminolevulinic acid Hydrochloride); FuMeiDa and Libord. Geographically, it derives revenue from Mainland China.
Executives
Invesco Hong Kong Limited 2102 Investment manager
Shanghai Pharmaceuticals Holding Co., Ltd.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Headlines

No Headlines